Naonori Kurokawa
Directeur/Membre du Conseil chez Quantum Biosystems, Inc.
Profil
Naonori Kurokawa is currently an Outside Director at Quantum Biosystems, Inc., Molcure, Inc., Adacotech, Inc., Provigate KK, and a Director at Elixirgen Therapeutics, Inc. He is also a Partner at The University of Tokyo Edge Capital Co. Ltd.
His former position was as an Outside Director at Microwave Chemical Co., Ltd.
Kurokawa holds a doctorate from Osaka University and an MBA from The University of Chicago Booth School of Business.
Postes actifs de Naonori Kurokawa
| Sociétés | Poste | Début |
|---|---|---|
The University of Tokyo Edge Capital Co. Ltd.
 The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | Private Equity Investor | 29/07/2010 |
Quantum Biosystems, Inc.
 Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Directeur/Membre du Conseil | - |
Molcure, Inc.
 Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - |
Provigate KK
 Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan. | Directeur/Membre du Conseil | - |
Elixirgen Therapeutics, Inc.
 Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | Directeur/Membre du Conseil | - |
Adacotech, Inc.
 Adacotech, Inc. Aerospace & DefenseElectronic Technology Adacotech, Inc. is a Japanese company that specializes in the research, development, manufacture, and sales of systems related to video surveillance and automatic recognition. The company is based in Tokyo, Japan. The company was founded in 2012. Ryota Kawamura has been the CEO of the company since 2019. | Directeur/Membre du Conseil | - |
Anciens postes connus de Naonori Kurokawa
| Sociétés | Poste | Fin |
|---|---|---|
| MICROWAVE CHEMICAL CO., LTD. | Directeur/Membre du Conseil | - |
Formation de Naonori Kurokawa
| Osaka University | Doctorate Degree |
| The University of Chicago Booth School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| MICROWAVE CHEMICAL CO., LTD. | Commercial Services |
| Entreprise privées | 6 |
|---|---|
The University of Tokyo Edge Capital Co. Ltd.
The University of Tokyo Edge Capital Co. Ltd. Investment ManagersFinance University of Tokyo Edge Capital Co Ltd (UTEC) is an independent venture capital firm with headquarters in Japan. UTEC was founded in 2004 and has an office in Tokyo, Japan. | Finance |
Quantum Biosystems, Inc.
Quantum Biosystems, Inc. BiotechnologyHealth Technology Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan. | Health Technology |
Molcure, Inc.
Molcure, Inc. BiotechnologyHealth Technology Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan. | Health Technology |
Provigate KK
Provigate KK Medical SpecialtiesHealth Technology Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan. | Health Technology |
Elixirgen Therapeutics, Inc.
Elixirgen Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD. | Health Technology |
Adacotech, Inc.
Adacotech, Inc. Aerospace & DefenseElectronic Technology Adacotech, Inc. is a Japanese company that specializes in the research, development, manufacture, and sales of systems related to video surveillance and automatic recognition. The company is based in Tokyo, Japan. The company was founded in 2012. Ryota Kawamura has been the CEO of the company since 2019. | Electronic Technology |